• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) Back to Search Results
Model Number G158
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Inappropriate/Inadequate Shock/Stimulation (1574); Delayed Charge Time (2586)
Patient Problem Electric Shock (2554)
Event Date 05/10/2022
Event Type  Injury  
Manufacturer Narrative
If the product is returned, analysis would be performed and this report would be updated at that time.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) recorded code 1007, message indicator that the shocking capacitors are not charged to the programmed voltage 45 seconds after the start of charging.Reportedly, the patient was received at the emergency room due to multiple shocks of atrial fibrillation with rapid ventricular response that exhausted the therapy.Technical services reviewed the case and indicated the issue could be related to an open circuit condition on the right ventricular (rv) lead.It was recommended to replace immediately this crt-d and the rv lead if the open circuit is confirmed.Subsequently, this crt-d was explanted, replaced and it is not expected to be returned for analysis.Reportedly, the shorted lead condition was discarded after the device data was remotely analyzed by engineering.The rv lead was working adequately.It appears that the device lost the ability to charge due to some other cause.No additional adverse patient effects were reported.
 
Manufacturer Narrative
If the product is returned, analysis would be performed and this report would be updated at that time.Upon receipt at our post market quality assurance laboratory, the cardiac resynchronization therapy defibrillator (crt-d) was thoroughly inspected and analyzed.Visual inspection found no anomalies.This product was put through and passed the returned products test, which involves a series of automated diagnostic testing that verifies the performance of pacing, sensing, shocking and recording functions of the device commensurate with battery voltage.The laboratory analysis found no evidence of device defect, malfunction or damage outside the bounds of normal medical use.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) recorded code 1007, message indicator that the shocking capacitors are not charged to the programmed voltage 45 seconds after the start of charging.Reportedly, the patient was received at the emergency room due to multiple shocks inappropriately given due to atrial fibrillation with rapid ventricular response that exhausted the therapy.Technical services reviewed the case and indicated the issue could be related to an open circuit condition on the right ventricular (rv) lead.It was recommended to replace immediately this crt-d and the rv lead if the open circuit is confirmed.Subsequently, this crt-d was explanted, replaced and was returned for analysis.Reportedly, the shorted lead condition was discarded after the device data was remotely analyzed by engineering.The rv lead was working adequately.It appears that the device lost the ability to charge due to some other cause.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN X4 CRT-D
Type of Device
CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key14537573
MDR Text Key292973778
Report Number2124215-2022-17220
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534904
UDI-Public00802526534904
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/26/2020
Device Model NumberG158
Device Catalogue NumberG158
Device Lot Number195115
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 05/10/2022
Initial Date FDA Received05/28/2022
Supplement Dates Manufacturer Received05/08/2023
Supplement Dates FDA Received05/09/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/09/2018
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age86 YR
Patient SexFemale
-
-